pharmacology of the neuromuscular junction Flashcards

1
Q

How do non-depolarising blockers act?

A

they are ANTAGONISTS of the NMJ - they Reversibly bind to the nicotinic acetyl choline receptor at the NMJ and prevent Ach from binding, decreasing the motor end plate potential.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How do non-depolarising blockers work?

A

they are AGONISTS of the NMJ - they work by causing prolonged depolarisation of the muscle membrane, which prevents the voltage-gated sodium channels from closing to regenerate an action potential (i.e. the sodium channels remain refractory)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is the first phase of a depolarising block?

A
  • muscle fasciculations, then muscle paralysis
  • repolarisation inhibited and potassium leaks from the cell causing hyperkalemia
  • voltage gated sodium channels kept inactivated
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is the second phase of a depolarising block?

A
  • prolonged/increasedexposure to drug

- desensitisation blockade

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is the ‘desensitisation blockade’?

A

this is when the nicotinic acetyl choline receptors close because of the effect of the depolarising blocker and will not open even in the present elf acetyl choline.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what is the suffix of the AMINOSTEROIDAL class of non-depolarising blockers?

A

-curonium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is the suffix for the BENZYLISOQUIOLINIUM class of non-depolarising blockers?

A

-curium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what are the 5 side effects of SUXAMETHONIUM?

A
  • bradychardia (slow HR)
  • cardiac dysrhythmias
  • raised intraocular pressure
  • postoperative myalgia (muscle fasciculations
  • malignant hyperthermia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

which NMJ blocking drugs are metabolised by PLASMA cholinesterase’s?

A

mivacurium and suxamethonium

these drugs are therefore short acting because the plasma cholinesterase breaks them down in the blood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

which NMJ blocking drugs are broken down in the liver and kidney?

A

pancuronium and vecuronium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is the effect of anti cholinesterase drugs?

A

they inhibit the cholinesterase enzymes and therefore prevent them from breaking down ACh. There is therefore more ACh to compete with the non-depolarising blockers on the active site of the nicotinic ACh receptors.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what are the two CLINICALLY used acetyl cholinesterase?

A

neostigmine and pyridostigmine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

how do the two clinically used acetyl cholinesterase work?

A

by formation of a carbamylated enzyme complex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what are two acetyl cholinesterase that are used NON-CLINICALLY?

A

dyflos and parathion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

how do dyflos and parathion work?

A

gy phosphorylating the active site of the cholinesterase enzymes (irreversible process)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the effects of anticholinesterases on the Autonomic nervous system?

A

SLUDGE
(Salivation, Lacrimation, Urination, Defecation, Gastrointestinal upset, Emesis)
Bradycardia, hypotension, bronchoconstriction, pupillary constriction (miosis)

17
Q

what are 4 clinical uses of anticholinesterases?

A
  • in anaesthesia (to reverse non-depolarising uncle blockade)
  • in Myasthenia Gravis (increases neuromuscular transmission)
  • Glaucoma (decreases intraocular pressure)
  • Alzheimer’s disease (enhance the cholinergic transmission in the CNS)
18
Q

what is Sugammadex?

A

a selective relaxant binding agent that reverses the effects of ROCURONIUM and VECURONIUM